 | • レポートコード：QYR2104Z0274 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、アルツハイマー病診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経系検査、遺伝子検査、ミニメンタルステート検査（Mmse）、脳画像）、用途別市場規模（早期発症型アルツハイマー病、家族性アルツハイマー病、遅発型アルツハイマー病）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アルツハイマー病診断の市場動向 ・企業の競争状況、市場シェア ・アルツハイマー病診断の種類別市場規模（神経系検査、遺伝子検査、ミニメンタルステート検査（Mmse）、脳画像） ・アルツハイマー病診断の用途別市場規模（早期発症型アルツハイマー病、家族性アルツハイマー病、遅発型アルツハイマー病） ・アルツハイマー病診断の北米市場規模2016-2027（アメリカ、カナダ） ・アルツハイマー病診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルツハイマー病診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルツハイマー病診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルツハイマー病診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Novartis、Merck、F. Hoffmann-La Roche、Pfizer、TauRx、Alector、Accera、Treventis Corporation、Neuro-Bio、Cognition Therapeutics） ・結論 |
The diagnosis of alzheimer’s disease is divided into three steps. The first step is to determine whether it is alzheimer’s disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or medial temporal lobe volume atrophy, and the apolipoprotein E4 allele.The third step is to determine the extent of the disease, which can be determined by a simple mental state examination or the patient’s response.
Market Analysis and Insights: Global Alzheimer’s Disease Diagnostic Market
The global Alzheimer’s Disease Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer’s Disease Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer’s Disease Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer’s Disease Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer’s Disease Diagnostic market.
Global Alzheimer’s Disease Diagnostic Scope and Market Size
Alzheimer’s Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nervous System Examination
Genetic Testing
Minor Mental State Examination (Mmse)
Brain Imaging
Segment by Application
Early-Onset Alzheimer’s Disease
Familial Alzheimer’s Disease
Late-Onset Alzheimer’s Disease
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly and Company
Novartis
Merck
F. Hoffmann-La Roche
Pfizer
TauRx
Alector
Accera
Treventis Corporation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nervous System Examination
1.2.3 Genetic Testing
1.2.4 Minor Mental State Examination (Mmse)
1.2.5 Brain Imaging
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Early-Onset Alzheimer’s Disease
1.3.3 Familial Alzheimer’s Disease
1.3.4 Late-Onset Alzheimer’s Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Diagnostic Market Perspective (2016-2027)
2.2 Alzheimer’s Disease Diagnostic Growth Trends by Regions
2.2.1 Alzheimer’s Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimer’s Disease Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimer’s Disease Diagnostic Industry Dynamic
2.3.1 Alzheimer’s Disease Diagnostic Market Trends
2.3.2 Alzheimer’s Disease Diagnostic Market Drivers
2.3.3 Alzheimer’s Disease Diagnostic Market Challenges
2.3.4 Alzheimer’s Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Diagnostic Revenue
3.4 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2020
3.5 Alzheimer’s Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2022-2027)
5 Alzheimer’s Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Alzheimer’s Disease Diagnostic Market Size (2016-2027)
6.2 North America Alzheimer’s Disease Diagnostic Market Size by Type
6.2.1 North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Application
6.3.1 North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
6.4 North America Alzheimer’s Disease Diagnostic Market Size by Country
6.4.1 North America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2016-2027)
7.2 Europe Alzheimer’s Disease Diagnostic Market Size by Type
7.2.1 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Application
7.3.1 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Country
7.4.1 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Diagnostic Market Size (2016-2027)
9.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Type
9.2.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Application
9.3.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Alzheimer’s Disease Diagnostic Market Size by Country
9.4.1 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
11.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
11.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
11.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.3.5 Merck Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
11.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 TauRx
11.6.1 TauRx Company Details
11.6.2 TauRx Business Overview
11.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
11.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.6.5 TauRx Recent Development
11.7 Alector
11.7.1 Alector Company Details
11.7.2 Alector Business Overview
11.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
11.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.7.5 Alector Recent Development
11.8 Accera
11.8.1 Accera Company Details
11.8.2 Accera Business Overview
11.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
11.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.8.5 Accera Recent Development
11.9 Treventis Corporation
11.9.1 Treventis Corporation Company Details
11.9.2 Treventis Corporation Business Overview
11.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
11.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.9.5 Treventis Corporation Recent Development
11.10 Neuro-Bio
11.10.1 Neuro-Bio Company Details
11.10.2 Neuro-Bio Business Overview
11.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
11.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.10.5 Neuro-Bio Recent Development
11.11 Cognition Therapeutics
11.11.1 Cognition Therapeutics Company Details
11.11.2 Cognition Therapeutics Business Overview
11.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
11.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021)
11.11.5 Cognition Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nervous System Examination
Table 3. Key Players of Genetic Testing
Table 4. Key Players of Minor Mental State Examination (Mmse)
Table 5. Key Players of Brain Imaging
Table 6. Global Alzheimer’s Disease Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alzheimer’s Disease Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Alzheimer’s Disease Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2016-2021)
Table 10. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2022-2027)
Table 12. Alzheimer’s Disease Diagnostic Market Trends
Table 13. Alzheimer’s Disease Diagnostic Market Drivers
Table 14. Alzheimer’s Disease Diagnostic Market Challenges
Table 15. Alzheimer’s Disease Diagnostic Market Restraints
Table 16. Global Alzheimer’s Disease Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Alzheimer’s Disease Diagnostic Market Share by Players (2016-2021)
Table 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2020)
Table 19. Ranking of Global Top Alzheimer’s Disease Diagnostic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Alzheimer’s Disease Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
Table 23. Date of Enter into Alzheimer’s Disease Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2016-2021)
Table 27. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Alzheimer’s Disease Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2016-2021)
Table 31. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly and Company Company Details
Table 64. Eli Lilly and Company Business Overview
Table 65. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product
Table 66. Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly and Company Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Alzheimer’s Disease Diagnostic Product
Table 71. Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Alzheimer’s Disease Diagnostic Product
Table 76. Merck Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 77. Merck Recent Development
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product
Table 81. F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Alzheimer’s Disease Diagnostic Product
Table 86. Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. TauRx Company Details
Table 89. TauRx Business Overview
Table 90. TauRx Alzheimer’s Disease Diagnostic Product
Table 91. TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 92. TauRx Recent Development
Table 93. Alector Company Details
Table 94. Alector Business Overview
Table 95. Alector Alzheimer’s Disease Diagnostic Product
Table 96. Alector Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 97. Alector Recent Development
Table 98. Accera Company Details
Table 99. Accera Business Overview
Table 100. Accera Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 101. Accera Recent Development
Table 102. Treventis Corporation Company Details
Table 103. Treventis Corporation Business Overview
Table 104. Treventis Corporation Alzheimer’s Disease Diagnostic Product
Table 105. Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 106. Treventis Corporation Recent Development
Table 107. Neuro-Bio Company Details
Table 108. Neuro-Bio Business Overview
Table 109. Neuro-Bio Alzheimer’s Disease Diagnostic Product
Table 110. Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 111. Neuro-Bio Recent Development
Table 112. Cognition Therapeutics Company Details
Table 113. Cognition Therapeutics Business Overview
Table 114. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product
Table 115. Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2016-2021) & (US$ Million)
Table 116. Cognition Therapeutics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer’s Disease Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Nervous System Examination Features
Figure 3. Genetic Testing Features
Figure 4. Minor Mental State Examination (Mmse) Features
Figure 5. Brain Imaging Features
Figure 6. Global Alzheimer’s Disease Diagnostic Market Share by Application: 2020 VS 2027
Figure 7. Early-Onset Alzheimer's Disease Case Studies
Figure 8. Familial Alzheimer's Disease Case Studies
Figure 9. Late-Onset Alzheimer's Disease Case Studies
Figure 10. Alzheimer’s Disease Diagnostic Report Years Considered
Figure 11. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Alzheimer’s Disease Diagnostic Market Share by Regions: 2020 VS 2027
Figure 14. Global Alzheimer’s Disease Diagnostic Market Share by Regions (2022-2027)
Figure 15. Global Alzheimer’s Disease Diagnostic Market Share by Players in 2020
Figure 16. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2020
Figure 18. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2016-2021)
Figure 19. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2022-2027)
Figure 20. North America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
Figure 22. North America Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
Figure 23. North America Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
Figure 24. United States Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
Figure 28. Europe Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
Figure 29. Europe Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
Figure 30. Germany Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Region (2016-2027)
Figure 40. China Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
Figure 48. Latin America Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
Figure 49. Latin America Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
Figure 50. Mexico Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Country (2016-2027)
Figure 56. Turkey Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Alzheimer’s Disease Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 64. TauRx Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 65. Alector Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 66. Accera Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 67. Treventis Corporation Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 68. Neuro-Bio Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 69. Cognition Therapeutics Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). …- 世界のアルツハイマー病診断市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のアルツハイマー病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Market Analysis and Insights: Glob…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2…